1. Home
  2. VIPS vs BLTE Comparison

VIPS vs BLTE Comparison

Compare VIPS & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

HOLD

Current Price

$16.17

Market Cap

7.7B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$149.51

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIPS
BLTE
Founded
2008
2018
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
6.5B
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
VIPS
BLTE
Price
$16.17
$149.51
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$19.83
$181.14
AVG Volume (30 Days)
1.9M
162.4K
Earning Date
02-26-2026
03-02-2026
Dividend Yield
3.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.11
N/A
Revenue Next Year
$1.77
$363.39
P/E Ratio
$9.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.14
$49.00
52 Week High
$21.08
$200.00

Technical Indicators

Market Signals
Indicator
VIPS
BLTE
Relative Strength Index (RSI) 47.99 33.37
Support Level $14.98 $148.78
Resistance Level $16.84 $161.28
Average True Range (ATR) 0.50 7.55
MACD 0.07 -2.25
Stochastic Oscillator 59.25 7.40

Price Performance

Historical Comparison
VIPS
BLTE

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: